[go: up one dir, main page]

FR3000403B1 - DERMATOLOGICAL COMPOSITION COMPRISING A SOLUBILIZED PDE7 INHIBITOR, ITS PREPARATION METHOD AND USE - Google Patents

DERMATOLOGICAL COMPOSITION COMPRISING A SOLUBILIZED PDE7 INHIBITOR, ITS PREPARATION METHOD AND USE

Info

Publication number
FR3000403B1
FR3000403B1 FR1262925A FR1262925A FR3000403B1 FR 3000403 B1 FR3000403 B1 FR 3000403B1 FR 1262925 A FR1262925 A FR 1262925A FR 1262925 A FR1262925 A FR 1262925A FR 3000403 B1 FR3000403 B1 FR 3000403B1
Authority
FR
France
Prior art keywords
solubilized
preparation
dermatological composition
pde7 inhibitor
pde7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1262925A
Other languages
French (fr)
Other versions
FR3000403A1 (en
Inventor
Emmanuelle Guillet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR1262925A priority Critical patent/FR3000403B1/en
Priority to PCT/FR2013/053241 priority patent/WO2014102497A1/en
Publication of FR3000403A1 publication Critical patent/FR3000403A1/en
Application granted granted Critical
Publication of FR3000403B1 publication Critical patent/FR3000403B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR1262925A 2012-12-28 2012-12-28 DERMATOLOGICAL COMPOSITION COMPRISING A SOLUBILIZED PDE7 INHIBITOR, ITS PREPARATION METHOD AND USE Expired - Fee Related FR3000403B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1262925A FR3000403B1 (en) 2012-12-28 2012-12-28 DERMATOLOGICAL COMPOSITION COMPRISING A SOLUBILIZED PDE7 INHIBITOR, ITS PREPARATION METHOD AND USE
PCT/FR2013/053241 WO2014102497A1 (en) 2012-12-28 2013-12-20 Dermatological composition comprising a pde7 inhibitor in a solubilised form, production method thereof, and use of same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262925A FR3000403B1 (en) 2012-12-28 2012-12-28 DERMATOLOGICAL COMPOSITION COMPRISING A SOLUBILIZED PDE7 INHIBITOR, ITS PREPARATION METHOD AND USE

Publications (2)

Publication Number Publication Date
FR3000403A1 FR3000403A1 (en) 2014-07-04
FR3000403B1 true FR3000403B1 (en) 2015-02-06

Family

ID=47989193

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1262925A Expired - Fee Related FR3000403B1 (en) 2012-12-28 2012-12-28 DERMATOLOGICAL COMPOSITION COMPRISING A SOLUBILIZED PDE7 INHIBITOR, ITS PREPARATION METHOD AND USE

Country Status (2)

Country Link
FR (1) FR3000403B1 (en)
WO (1) WO2014102497A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2433943B1 (en) * 2004-07-01 2013-09-11 Daiichi Sankyo Company, Limited Intermediates for thienopyrazole derivatives having PDE7 inhibitory activity
FR2878442B1 (en) * 2004-11-29 2008-10-24 Aventis Pharma Sa THIENO (2,3-c) SUBSTITUTED PYRAZOLES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING SAME AND USE THEREOF

Also Published As

Publication number Publication date
FR3000403A1 (en) 2014-07-04
WO2014102497A1 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
BR112015002541A2 (en) compound, pharmaceutical composition, use of a compound, and method for treating hcv in a patient.
BR112012022879A2 (en) compound, pharmaceutical composition, compound use and treatment method
BR112014023937A2 (en) pharmaceutical composition, pharmaceutical combination and treatment method
ZA201503753B (en) Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
SG11201406085TA (en) Method and system for operating winches, and use thereof
ZA201501541B (en) Supported catalyst and active form thereof, and preparation method and use thereof
BR112012031232A2 (en) method, device and use
HUE037607T2 (en) Liquid composition for biological pest management, method for preparation and use
ITMI20111404A1 (en) SUPPORT FOR HUMAN JOINTS.
BR112012016424A2 (en) apparatus, and method.
FR2959733B1 (en) CRANE AND METHOD FOR RAISING THE CRANE.
BR112014026873A2 (en) cosmetic method, cosmetic composition and use.
FR2986795B1 (en) COSMETIC COMPOSITION COMPRISING A MULTIFUNCTIONAL COMPOUND, COMPOUND AND COSMETIC PROCESSING METHOD
DK2816947T3 (en) ENDOSCOPIC DEVICE, IN PARTICULAR FOR MEDICAL USE
EP2687549A4 (en) Lipophilic, highly branched polymer, and photopolymerizable composition containing the same
BR112015015040A2 (en) solid or semi-solid composition, method for preparing the composition and using the composition
BR112015001843A2 (en) medical device, biodegradable matrix composition and method for treating a patient.
BR112014007007A2 (en) early differentiation method, fibrillation diagnostic method, cardiac troponin use, differentiation device and diagnostic device
IL239146A0 (en) Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs
EP2937541A4 (en) Measuring implement, measuring system and measuring method
FR2950253B1 (en) LIPID NANOCAPSULES, PREPARATION METHOD AND USE AS MEDICAMENT
EP3037099A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
EP2687532A4 (en) NOVEL OCTAHYDROTHENOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE, AND USE THEREOF
BR112014027027A2 (en) cosmetic composition, cosmetic method and use of a combination.
FR2991174B1 (en) DERMATOLOGICAL COMPOSITION COMPRISING OLEOSOMES AND RETINOIDS, PROCESS FOR PREPARING SAME AND USE THEREOF

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831